March 1, 2013 (Vol. 33, No. 5)

Cytovance Biologics added Maria Lopez as vp of quality. Prior to Cytovance, she served as the site quality head at Novartis. Before Novartis, Lopez held the position of director of quality and manager of quality assurance at Immucor. Prior to this, she was a scientist with Valentis.

Maria Lopez

Foundation Medicine hired Steven J. Kafka, Ph.D., as CBO…Bristol-Myers Squibb hired Mike Burgess, M.D., Ph.D., as svp, discovery medicine and clinical pharmacology…Novozymes hired Peder Holk Nielsen as president and CEO…Connexion added Chirag K. Patel as senior medical director…A5 Laboratories named Frank Neukomm as chairman and CEO and Robert Farr as COO and president…Cytox hired Richard Pither as CEO.

Tranzyme Pharma promoted David S. Moore as chief business officer. Moore joined Tranzyme in August 2011. Prior to that, he was vp, commercial operations at Johnson & Johnson.

David S. Moore

Ralf Wagner, Ph.D., is now managing director at Lophius Biosciences…Bassam Damaj, Ph.D., joined Innovus Pharmaceuticals as president and CEO…Atherotech Diagnostics Lab elected Peter A. McCullough, M.D., to its medical advisory board…Acadia Pharmaceuticals named Stephen R. Biggar, M.D., Ph.D., to its board of directors…Anika Therapeutics added Sylvia Cheung as CFO…Rexahn Pharmaceuticals hired Peter D. Suzdak, Ph.D., as CEO.

MyoKardia hired Jonathan C. Fox, M.D., Ph.D., as CMO. Before joining MyoKardia, he served as vp of clinical development at AstraZeneca. Formerly, he was senior director, clinical cardiovascular research at Merck, and he was director of clinical pharmacology at SmithKline Beecham.

Jonathan C. Fox, M.D., Ph.D.

OXiGENE appointed Dai Chaplin, Ph.D., to its board of directors…Warren Whitehead joined Amorfix Life Sciences as CFO…Jason Rifkin is now president of PreScience Labs…Mirna Therapeutics named Clay B. Siegall, Ph.D., to its board of directors…Affymax promoted Christine Conroy to svp, regulatory affairs and quality assurance and Tim Varacek to vp, sales and account management.

Galectin Therapeutics added Rex Horton as executive director of regulatory affairs and quality assurance. Most recently, Horton was director of regulatory affairs at Chelsea Therapeutics. Previously, he held roles at Solvay Pharmaceuticals and Abbott Laboratories.

Rex Horton

Gyros appointed Claus Braestrup, M.D., Ph.D., to its board of directors…Lumora added Hayden Jeffreys as commercial director…Aesica hired Jarrett Palmer as operations director of its formulated products business unit…Specialized Medical Services-oncology appointed Edwin Klumper as CEO, Philine van den Tol as COO, Eric van der Putten as CBDO, Wouter Wijkeras as managing director biometrics unit, and Raymond Hoffmans as director consultancy.

Edward C. Albini is now CFO at Sutro Biopharma. Previously, he held the CFO position at Itero Biopharmaceuticals, Novacea, and Lynx Therapeutics. Albini has also served as director of finance for international operations and director of financial planning and analysis at Genentech.

Edward C. Albini

JenaValve Technology named John F. Migliazza as COO…Recipharm Pharmaceutical Development appointed Hans Lennernäs, Ph.D., to its board of directors…OPX Biotechnologies added David Hogsett as vp of research and development and chief technology officer…Ruthigen hired Sameer Harish as CFO…Grant Gardiner joined Nordion as svp, general counsel and corporate secretary.

Michael Riebe, Ph.D., joined Pearl Therapeutics as vp, pharmaceutical development and research. Previously, he was vp of R&D at iCeutica. Prior to that, Dr. Riebe was senior scientific director in respiratory product development at Merck.

Michael Riebe, Ph.D.

BioLife Solutions appointed Rick Stewart to its board of directors…Alon Natanson is now CEO at BrainStorm Cell Therapeutics…Arno Therapeutics named Randy Thurman to its board of directors…SkilaMederi hired Raymond Joske as CCO…Protea Biosciences appointed Thijs Spoor and Josiah T. Austin to its board of directors…ULURU appointed Helmut Kerschbaumer and Klaus Kuehne to its board of directors…Meredian added Isao Noda, Ph.D., as director of innovative solutions.

Send your People Announcements to [email protected].

Previous articleTakeda, Resolve Join in $255M+ Lupus Drug Development Deal
Next articleBaxter Buys Long-Idled Manufacturing Plant for Bargain Basement Price